Ron is Senior Vice President, Translational Discovery at Recursion, a technology-enabled drug discovery company combining machine learning with automated cell biology. At Recursion, his team manages commercial and translational strategy for Recursion’s portfolio. He received training in Medicine, as well as Neurosciences & Genetics at Stanford University where his work contributed to the discovery of new hormone signals in humans. He has also worked closely with entrepreneurs and start-ups at Stanford-affiliated accelerator, StartX. Ron’s passion is to bring new medicines to patients at a scale never before achieved.